(Pyridin-4-yl)boronic acid → 8-Chloro-11-(pyridin-4-yl)-5h-dibenzo[b,e][1,4]diazepine
Reaction equation
B(O)(O)[C:2]1[CH:7]=[CH:6][N:5]=[CH:4][CH:3]=1.[Cl:10][C:11]1[CH:12]=[CH:13][C:14]2[N:20](Cl)[C:19]3[CH:22]=[CH:23][CH:24]=[CH:25][C:18]=3[CH:17]=[N:16][C:15]=2[CH:26]=1>>[Cl:10][C:11]1[CH:12]=[CH:13][C:14]2[NH:20][C:19]3[CH:22]=[CH:23][CH:24]=[CH:25][C:18]=3[C:17]([C:2]3[CH:7]=[CH:6][N:5]=[CH:4][CH:3]=3)=[N:16][C:15]=2[CH:26]=1Participants
3
Procedure
4 pyridyl-4-boronic acid (14 mg, 0.12 mmol) and 8,5-dichloro-5H-dibenzo[b,e][1,4]diazepine (160FE64) (26 mg, 0.1 mmol) were reacted according GP11 to give 9.3 mg of the title compound (160FE69A). MS (ESI) 306 (MH+). Purity for MH+ (UV/MS) 98/95.
Sources & evidence
- ORD record
- ord-ca014baffbb44b7da8bffd09dec4603b
- Source dataset
- uspto-grants-2009_04
- Patent number
- US07517871B2
Reaction notes
Loading…